Market Tracker

08/21 12:02pm ET
53.20
Real-Time Quote
 -0.90 / -1.66%
Today’s Change
10.95
Today|||52-Week Range
55.24
+261.17%
Year-to-Date

Today’s Trading

Previous close54.10
Today’s open53.50
Day’s range52.50 - 54.50
Volume1,078,851
Average volume (3 months)2,087,755
Market cap$5.8B
Dividend yield--
Data as of 11:46am ET, 08/21/2014

Growth & Valuation

Earnings growth (last year)-17.39%
Earnings growth (this year)-0.93%
Earnings growth (next 5 years)+60.00%
Revenue growth (last year)+168.74%
P/E ratioNM
Price/Sales17.04
Price/Book36.10

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA+0.23+0.61%
GEVASynageva BioPharma C...-1.58-2.19%
XONIntrexon Corp-0.79-3.84%
OPHTOphthotech Corp-1.12-2.93%
Data as of 12:01pm ET, 08/21/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)-$0.68
Annual revenue (last year)$70.3M
Annual profit (last year)-$219.6M
Net profit margin-313.88%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Daniel G. Welch
Executive VP, Chief Financial &
Accounting Officer
John C. Hodgman
Corporate headquarters
Brisbane, California

Forecasts